CFM
Catalyst Funds Management Portfolio holdings
AUM
$362M
1-Year Return
42.71%
This Quarter Return
+7.61%
1 Year Return
+42.71%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$373M
AUM Growth
+$14.7M
(+4.1%)
Cap. Flow
+$16.4M
Cap. Flow
% of AUM
4.4%
Top 10 Holdings %
Top 10 Hldgs %
46.87%
Holding
1,707
New
616
Increased
178
Reduced
304
Closed
565
Top Buys
| 1 |
Apple
AAPL
|
+$61.8M |
| 2 |
3M
MMM
|
+$18.6M |
| 3 |
Nu Holdings
NU
|
+$15.9M |
| 4 |
Broadcom
AVGO
|
+$14.2M |
| 5 |
Spotify
SPOT
|
+$12.3M |
Top Sells
| 1 |
Walmart
WMT
|
+$10.9M |
| 2 |
Kenvue
KVUE
|
+$7.2M |
| 3 |
Newmont
NEM
|
+$6M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$5.92M |
| 5 |
Meta Platforms (Facebook)
META
|
+$5.55M |
Sector Composition
| 1 | Technology | 33.66% |
| 2 | Industrials | 12.6% |
| 3 | Financials | 12.32% |
| 4 | Communication Services | 12.12% |
| 5 | Consumer Discretionary | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALEX
776
Alexander & Baldwin
ALEX
$1.37B
| $15.3K | ﹤0.01% |
900
+60
| +7% | +$1.02K |
|
|
VERV
777
DELISTED
Verve Therapeutics
VERV
| $15.1K | ﹤0.01% |
+3,100
| New | +$15.1K |
|
778
Cytek Biosciences
CTKB
$527M
| $15.1K | ﹤0.01% |
2,700
+2,400
| +800% | +$13.4K |
|
|
IVAC
779
DELISTED
Intevac Inc
IVAC
| $15.1K | ﹤0.01% |
+3,900
| New | +$15.1K |
|
780
AnaptysBio
ANAB
$647M
| $15K | ﹤0.01% |
600
-3,600
| -86% | -$90.2K |
|
781
SKYX Platforms
SKYX
$133M
| $15K | ﹤0.01% |
+15,800
| New | +$15K |
|
782
Loews
L
$20.4B
| $14.9K | ﹤0.01% |
+200
| New | +$14.9K |
|
783
Veritone
VERI
$195M
| $14.9K | ﹤0.01% |
+6,600
| New | +$14.9K |
|
784
Crown Holdings
CCK
$11.4B
| $14.9K | ﹤0.01% |
+200
| New | +$14.9K |
|
785
ICF International
ICFI
$1.82B
| $14.8K | ﹤0.01% |
+100
| New | +$14.8K |
|
786
Sensient Technologies
SXT
$4.57B
| $14.8K | ﹤0.01% |
200
-500
| -71% | -$37.1K |
|
787
TransUnion
TRU
$18.1B
| $14.8K | ﹤0.01% |
+200
| New | +$14.8K |
|
788
Adient
ADNT
$2B
| $14.8K | ﹤0.01% |
600
-900
| -60% | -$22.2K |
|
789
Gentherm
THRM
$1.1B
| $14.8K | ﹤0.01% |
300
+100
| +50% | +$4.93K |
|
790
Fate Therapeutics
FATE
$116M
| $14.8K | ﹤0.01% |
4,500
-14,300
| -76% | -$46.9K |
|
|
RC
791
Ready Capital
RC
$698M
| $14.7K | ﹤0.01% |
1,800
+1,000
| +125% | +$8.18K |
|
792
Tompkins Financial
TMP
$1.01B
| $14.7K | ﹤0.01% |
+300
| New | +$14.7K |
|
793
Children's Place
PLCE
$163M
| $14.7K | ﹤0.01% |
+1,800
| New | +$14.7K |
|
|
NIU
794
Niu Technologies
NIU
$321M
| $14.6K | ﹤0.01% |
8,400
| – | – |
|
795
Westamerica Bancorp
WABC
$1.26B
| $14.6K | ﹤0.01% |
300
-1,500
| -83% | -$72.8K |
|
796
Dana Inc
DAN
$2.79B
| $14.5K | ﹤0.01% |
1,200
+300
| +33% | +$3.64K |
|
797
Brinker International
EAT
$7.07B
| $14.5K | ﹤0.01% |
200
+100
| +100% | +$7.24K |
|
|
ELME
798
Elme Communities
ELME
$1.51B
| $14.3K | ﹤0.01% |
900
| – | – |
|
799
Zentalis Pharmaceuticals
ZNTL
$114M
| $14.3K | ﹤0.01% |
3,500
-5,800
| -62% | -$23.7K |
|
|
GRTS
800
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $14.3K | ﹤0.01% |
+23,100
| New | +$14.3K |
|